Filing Details

Accession Number:
0001127602-24-009007
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-07 16:10:27
Reporting Period:
2024-03-06
Accepted Time:
2024-03-07 16:10:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1462354 A Kurt Gustafson C/O Xencor, Inc.
465 N Halstead Street, Suite 200
Pasadena CA 91107
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-03-06 15,000 $10.73 20,007 No 4 M Direct
Common Stock Disposition 2024-03-06 14,000 $23.18 6,007 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-03-06 15,000 $0.00 15,000 $10.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-07-13 No 4 M Direct
Footnotes
  1. Underlying option due to expire in July 2024.
  2. Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
  3. 1/3 of the shares subject to the stock option vest and become exercisable on July 14, 2015, and the remaining shares vest in equal monthly installments over the subsequent 24 months.